GOV UK,Sugemalimab approved to treat adult patients with non-small cell lung cancer
Sugemalimab Approved to Treat Adult Patients with Non-Small Cell Lung Cancer London, 30 October 2024 – The Medicines and Healthcare products Regulatory Agency (MHRA) has approved sugemalimab for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumours express PD-L1 with a Combined Positive Score (CPS) of ≥1%. … Read more